Market Overview

Biomax Software Licensed by Royal DSM N.V. to Implement an AI-Augmented Semantic Search Platform for Global Research


Biomax Informatics AG announces that their longtime client, Royal DSM
N.V., has signed a multi-year license for the Biomax "semantic search"
technology to implement their new enterprise knowledge platform for
fast, simple and comprehensive knowledge discovery.

The Biomax™ semantic search technology provides an extensible framework
that automatically maintains a growing and evolving semantic network.
The platform works with in-house documents such as R&D archives as well
as public data resources. It integrates seamlessly with existing
infrastructure and helps leverage knowledge buried both in decades old
data as well as data derived from news feeds -- providing real-time
semantic analysis of breaking news.

Leveraging semantic networks, the search platform contains a
sophisticated question answering system using Artificial Intelligence
(AI)-augmented search algorithms. The extensible semantic network
connects and gets more sustainable value from the ever-increasing wealth
of knowledge generated by DSM research across all domains.

"DSM and Biomax already have a long-standing relationship and I am happy
that we can expand this relationship into building a knowledge platform
for DSM research. Better knowledge discovery for DSM is pivotal in
achieving our innovation ambition for the coming years," comments Dr.
Marcus Remmers, CTO Royal DSM N.V.

Biomax Informatics CEO, Dr. Klaus Heumann added, "We are excited to
contribute to DSM's ambition to be at the forefront of innovation by
deploying our semantic search technology company-wide for better time
management, increased effectiveness and accelerated productivity."

About Royal DSM
Royal DSM is a global science-based company
active in health, nutrition and materials. By connecting its unique
competences in life sciences and materials sciences DSM is driving
economic prosperity, environmental progress and social advances to
create sustainable value for all stakeholders simultaneously. DSM
delivers innovative solutions that nourish, protect and improve
performance in global markets such as food and dietary supplements,
personal care, feed, medical devices, automotive, paints, electrical and
electronics, life protection, alternative energy and bio-based
materials. DSM and its associated companies deliver annual net sales of
about €10 billion with approximately 25,000 employees.

About Biomax
provides computational solutions for better decision
making and knowledge management in the life sciences. They help
customers generate value by integrating information from proprietary and
public resources to enable a knowledge-based approach to developing
innovative life science products. Biomax's worldwide customer community
includes clinics, companies and research organizations that are
successful in drug discovery, diagnostics, fine chemicals, food and
plant production.


Biomax is a registered trademarks of Biomax Informatics AG in Germany
and other countries. Registered names, trademarks, etc., used in this
document, even when not specifically marked as such, are not to be
considered unprotected by law.

View Comments and Join the Discussion!
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at